In obese and coronary artery disease patients, high levels of HDL containing apoE but lacking apoCIII are associated with reduced coronary plaque burden and cardiovascular risk, whereas HDL containing both apoE and apoCIII are associated with increased disease burden and cardiovascular risk (64, 65). The gene discussed is APOE; the disease is coronary artery disorder.